PMC:7696151 / 75834-75989
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2243 | 55-60 | Species | denotes | human | Tax:9606 |
| 2246 | 121-124 | Chemical | denotes | HCQ | MESH:D006886 |
| 2261 | 9-15 | Disease | denotes | cancer | MESH:D009369 |
| 2262 | 31-38 | Disease | denotes | ovarian | MESH:D010049 |
| 2263 | 61-74 | Disease | denotes | breast cancer | MESH:D001943 |
| 2264 | 143-148 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T149 | 9-15 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
| T150 | 61-74 | Phenotype | denotes | breast cancer | http://purl.obolibrary.org/obo/HP_0003002 |
| T151 | 143-148 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T486 | 0-155 | Sentence | denotes | In other cancer types, such as ovarian, prostatic, and human breast cancer, the anticancer or pro-tumorigenic effects of HCQ are determined by tumor stage. |